resident of Cambridge's "Genetown," Genzyme has a unique pharmaceutical marketing
niche: developing treatments and products for rare genetic diseases. One of Genzyme's
triumphs is its star product, Cerezyme, a drug used to treat Gaucher's disease,
which causes symptoms of fatigue, anemia, and bone loss. In addition, Genzyme,
founded in 1981, provides genetic tests for expectant parents and is the leading
developer of tissue repair products used to treat cartilage damage, severe burns,
and chronic skin ulcers.